Is Inovio Pharmaceuticals a Ticking Time Bomb For Investors?
Inovio Pharmaceuticals (NASDAQ: INO) shares have surged 109% since the beginning of the year on optimism about the company's work on a vaccine for COVID-19, the illness caused by the novel coronavirus. Inovio isn't alone. As the coronavirus outbreak expanded, now totaling two million cases worldwide, many companies working on treatments or prevention moved into the spotlight.
While it's exciting to see their shares rising now, in some cases -- like that of Inovio -- I'm concerned about what will happen to stock performance once the coronavirus outbreak is over. Inovio shares have already given back some gains. They were up as much as 327% year to date at their peak last month. Does this mean the stock is a ticking time bomb for investors? Let's take a look.
Image source: Getty Images.
Source Fool.com
